• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

July 30, 2015 | Cell
Luke N. Robinson et al.

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Luke N. Robinson, Kannan Tharakaraman, Kirk J. Rowley, Vivian V. Costa, Kuan Rong Chan, Yee Hwa Wong, Li Ching Ong, Hwee Cheng Tan, Tyree Koch, David Cain, Rama Kirloskar, Karthik Viswanathan, Chong Wai Liew, Hamid Tissire, Boopathy Ramakrishnan, James R. Myette, Gregory J. Babcock, V. Sasisekharan, Sylvie Alonso, Jianzhu Chen, Julien Lescar, Zachary Shriver, Eng Eong Ooi, Ram Sasisekharan

>READ

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design